Ani Pharmaceuticals (ANIP) Amortizatization of Intangibles (2023 - 2026)

Ani Pharmaceuticals has disclosed Amortizatization of Intangibles across 4 years of filings, most recently posting $456000.0 for Q2 2026.

• In Q2 2026, Amortizatization of Intangibles rose 15.74% year-over-year to $456000.0; the TTM figure through Jun 2026 stood at $1.8 million (up 12.33% YoY), while the FY2025 annual figure was $1.8 million, up 15.27% from the prior year.
• Amortizatization of Intangibles came in at $456000.0 for Q2 2026 at Ani Pharmaceuticals, up from $453000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $827000.0 in Q3 2023 to a low of $61000.0 in Q2 2023.
• Average Amortizatization of Intangibles over 4 years is $420230.8, with a median of $392000.0 recorded in 2024.
• The largest YoY upside for Amortizatization of Intangibles was 518.03% in 2024 against a maximum downside of 53.57% in 2024.
• Over 4 years, Amortizatization of Intangibles stood at $381000.0 in 2023, then gained by 2.89% to $392000.0 in 2024, then jumped by 41.58% to $555000.0 in 2025, then dropped by 17.84% to $456000.0 in 2026.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $456000.0 in Q2 2026, $453000.0 in Q1 2026, and $555000.0 in Q4 2025.